Rosebud Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $275K

  • Investors
  • 9

Rosebud Biosciences General Information

Description

Developer of a drug discovery platform designed to provide therapies for rare genetic diseases in children. The company's platform specializes in modelling human development with organoids that have the same gene mutation as the child and screens drugs in these models to find cures using machine learning and the latest molecular advances, enabling doctors to minimize the cost and time for pre-clinical testing of novel and repurposed drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 63 Via Floreado
  • Orinda, CA 94563-1924
  • United States
+1 (805)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 63 Via Floreado
  • Orinda, CA 94563-1924
  • United States
+1 (805)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosebud Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 15-Aug-2023 $275K Completed Product Development
3. Early Stage VC 14-Apr-2022 Completed Product Development
2. Accelerator/Incubator 29-Mar-2022 $500K $500K Completed Product Development
1. Early Stage VC (Series 1) 27-Mar-2022 Completed Product Development
To view Rosebud Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rosebud Biosciences Patents

Rosebud Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4463552-A2 Bancr compositions and methods for treating disease Pending 14-Jan-2022
EP-4463552-A4 Bancr compositions and methods for treating disease Pending 14-Jan-2022
US-20250092394-A1 Bancr compositions and methods for treating disease Pending 14-Jan-2022
WO-2023137260-A2 Bancr compositions and methods for treating disease Inactive 14-Jan-2022
WO-2023137260-A3 Bancr compositions and methods for treating disease Inactive 14-Jan-2022 C12N15/113
To view Rosebud Biosciences’s complete patent history, request access »

Rosebud Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rosebud Biosciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
10X Capital Venture Capital Minority
Arvantis Group Holding Company Minority
Gaingels Venture Capital Minority
Y Combinator Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

Rosebud Biosciences FAQs

  • When was Rosebud Biosciences founded?

    Rosebud Biosciences was founded in 2020.

  • Where is Rosebud Biosciences headquartered?

    Rosebud Biosciences is headquartered in Orinda, CA.

  • What is the size of Rosebud Biosciences?

    Rosebud Biosciences has 4 total employees.

  • What industry is Rosebud Biosciences in?

    Rosebud Biosciences’s primary industry is Drug Discovery.

  • Is Rosebud Biosciences a private or public company?

    Rosebud Biosciences is a Private company.

  • What is Rosebud Biosciences’s current revenue?

    The current revenue for Rosebud Biosciences is .

  • How much funding has Rosebud Biosciences raised over time?

    Rosebud Biosciences has raised $500K.

  • Who are Rosebud Biosciences’s investors?

    US National Science Foundation, 10X Capital, Arvantis Group, Gaingels, and Y Combinator are 5 of 9 investors who have invested in Rosebud Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process